Ali Azhdarinia

This paper identifies fibulin-4 as a marker of metastatic breast cancer and demonstrates the use of BLMP6-based probes and therapeutics for detection and treatment.

This paper shows that hematopoietic stem and progenitor cells express somatostatin receptors, leading to unexpected toxicity from radiopharmaceuticals used in neuroendocrine tumors.

This study investigates SSTR2 overexpression in HCC, finding it correlates with poor survival and oncogenic pathways, suggesting it as a therapeutic target and theranostic biomarker.

This study evaluates SSTR2-targeted theranostics for hepatocellular carcinoma, showing SSTR2 expression and effective radioligand uptake and cytotoxicity in preclinical and clinical settings.

This study develops and tests EREG-targeting ADCs showing efficacy in both RAS mutant and wildtype CRC, with high potency and safety in preclinical models.